KRKA: Audited consolidated and unconsolidated annual report for the year 2013

2014-04-03 12:07

publikacja
2014-04-03 12:07

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
Audited_consolidated_and_unconsolidated_annual_report_for_the_year_2013.pdf (REPORT)
WSE_-_Report_on_compliance_with_the_Corporate_Governance_Rules_of_the_Warsaw_Stock_Exchange_for_the_year_2013.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		11	/	2014
Date of issue:	2014-04-03
Short name of the issuer
KRKA
Subject
Audited consolidated and unconsolidated annual report for the year 2013
Official market - legal basis
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
Unofficial market - legal basis
Contents of the report:
See attached documents.
Annexes
File			Description
Audited consolidated and unconsolidated annual report for the year 2013.pdfAudited consolidated and unconsolidated annual report for the year 2013.pdf			Annual report 2013
WSE - Report on compliance with the Corporate Governance Rules of the Warsaw Stock Exchange for the year 2013.pdfWSE - Report on compliance with the Corporate Governance Rules of the Warsaw Stock Exchange for the year 2013.pdf			Corporate Governance Rules

KRKA, TOVARNA ZDRAVIL D.D.

(fullname of the issuer)

KRKA

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

8501

Nove Mesto

(post code)

(city)

Smarjeska

(street)

(number)

+386 7 331 21 11

+386 7 332 15 37

(phone number)

(fax)

(e-mail)

(web site)

SI82646716

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2014-04-03	Jože Colarič	President of the Management Board

Ważne linki